Korean J Radiol.  2018 Aug;19(4):606-612. 10.3348/kjr.2018.19.4.606.

A Prospective Randomized Comparison of a Covered Metallic Ureteral Stent and a Double-J Stent for Malignant Ureteral Obstruction

• Kim JW
• Hong B
• Shin JH
• Park J
• Kim JH
• Gwon DI
• Ryu MH
• Ryoo BY

• KMID: 2413690
• DOI: http://doi.org/10.3348/kjr.2018.19.4.606

Abstract

OBJECTIVE
To compare the safety and efficacy between a covered metallic ureteral stent (CMS) and a double-J ureteral stent (DJS) for the treatment of a malignant ureteral obstruction (MUO).
MATERIALS AND METHODS
Nineteen patients (seven men and 12 women; mean age, 53.4 years) were randomly assigned to the CMS (n = 10) or DJS (n = 9) group. The following were compared between the two groups: technical success, i.e., successful stent placement into desired locations; stent malfunction; stent patency, i.e., no obstruction and no additional intervention; complications; and patient survival.
RESULTS
The technical success rate was 100% in all 10 and 12 ureteral units in the CMS and DJS groups, respectively. During the mean follow-up period of 253.9 days (range, 63-655 days), stent malfunction was observed in 40.0% (4/10) and 66.7% (8/12) in the CMS and DJS groups, respectively. In the per-ureteral analysis, the median patency time was 239.0 days and 80.0 days in the CMS and DJS groups, respectively. The CMS group yielded higher patency rates compared with the DJS group at three months (90% vs. 35%) and at six months (57% vs. 21%). The overall patency rates were significantly higher in the CMS group (p = 0.041). Complications included the migration of two metallic stents in one patient in the CMS group, which were removed in a retrograde manner. The two patient groups did not differ significantly regarding their overall survival rates (p = 0.286).
CONCLUSION
Covered metallic ureteral stent may be effective for MUO.

Keyword

Ureter obstruction; Ureter stent; Metallic ureter stent; Double-J ureter stent; Covered ureter stent; Random; Study; Trial

MeSH Terms

Female
Follow-Up Studies
Humans
Male
Prospective Studies*
Stents*
Survival Rate
Ureter*
Ureteral Obstruction*

Figure

• 

  Fig. 1 Structure of silicone-covered, self-expandable, metallic stent (Urexel, S&G Biotech). A. Both ends are fully covered with silicone membrane, and distally tapered shape is shown with 1-mm difference in diameter between proximal and distal ends. B. Comparison of Urexel metallic ureteral stent and DJS. DJS = double-J ureteral stent

• 

  Fig. 2 55-year-old, male patient with advanced gastric cancer. A. Enhanced axial CT image shows hydronephrosis of left kidney (arrow) that was caused by periureteric metastasis. B. Antegrade pyelogram via percutaneous nephrostomy tube shows diffuse, long-segmental ureteric strictures (arrows) from proximal- to mid-ureter. C. Antegrade pyelogram immediately following metallic ureteral stents placement shows good flow of contrast medium through metallic ureteral stents into urinary bladder. D. Follow-up enhanced CT image obtained one month after metallic ureteral stents placement shows complete resolution of hydronephrosis of left kidney (arrow). CT = computed tomography

• 

  Fig. 3 Kaplan-Meier curve of primary patency rates of both stent groups. Overall patency rates were significantly higher in CMS group compared with DJS group (log-rank test, p = 0.041). CMS = covered metallic ureteral stent

• 

  Fig. 4 Kaplan-Meier curve of survival rates of both stent groups. Two groups did not differ significantly regarding overall survival rates (log-rank test, p = 0.286).

Reference

1. Better OS, Arieff AI, Massry SG, Kleeman CR, Maxwell MH. Studies on renal function after relief of complete unilateral ureteral obstruction of three months' duration in man. Am J Med. 1973; 54:234–240.

2. Russo P. Urologic emergencies in the cancer patient. Semin Oncol. 2000; 27:284–298.

3. Farrell TA, Hicks ME. A review of radiologically guided percutaneous nephrostomies in 303 patients. J Vasc Interv Radiol. 1997; 8:769–774.

4. Radecka E, Magnusson A. Complications associated with percutaneous nephrostomies. A retrospective study. Acta Radiol. 2004; 45:184–188.

5. Saltzman B. Ureteral stents. Indications, variations, and complications. Urol Clin North Am. 1988; 15:481–491.

6. Chung SY, Stein RJ, Landsittel D, Davies BJ, Cuellar DC, Hrebinko RL, et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol. 2004; 172:592–595.

7. Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: experience at 2 institutions. J Urol. 1989; 142(2 Pt 1):277–279.

8. Lang EK, Winer AG, Abbey-Mensah G, Anne R, Allaei A, Friedman F, et al. Long-term results of metallic stents for malignant ureteral obstruction in advanced cervical carcinoma. J Endourol. 2013; 27:646–651.

9. Wang HJ, Lee TY, Luo HL, Chen CH, Shen YC, Chuang YC, et al. Application of resonance metallic stents for ureteral obstruction. BJU Int. 2011; 108:428–432.

10. Kim JH, Song K, Jo MK, Park JW. Palliative care of malignant ureteral obstruction with polytetrafluoroethylene membrane-covered self-expandable metallic stents: initial experience. Korean J Urol. 2012; 53:625–631.

11. Trueba Arguiñarena FJ, Fernández del Busto E. Self-expanding polytetrafluoroethylene covered nitinol stents for the treatment of ureteral stenosis: preliminary report. J Urol. 2004; 172:620–623.

12. Pollak JS, Rosenblatt MM, Egglin TK, Dickey KW, Glickman M. Treatment of ureteral obstructions with the Wallstent endoprosthesis: preliminary results. J Vasc Interv Radiol. 1995; 6:417–425.

13. Chung HH, Lee SH, Cho SB, Park HS, Kim YS, Kang BC, et al. Comparison of a new polytetrafluoroethylene-covered metallic stent to a noncovered stent in canine ureters. Cardiovasc Intervent Radiol. 2008; 31:619–628.

14. Chung KJ, Park BH, Park B, Lee JH, Kim WJ, Baek M, et al. Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa™) in malignant ureteral obstructions. J Endourol. 2013; 27:930–935.

15. Kim KS, Choi S, Choi YS, Bae WJ, Hong SH, Lee JY, et al. Comparison of efficacy and safety between a segmental thermo-expandable metal alloy spiral stent (Memokath 051) and a self-expandable covered metallic stent (UVENTA) in the management of ureteral obstructions. J Laparoendosc Adv Surg Tech A. 2014; 24:550–555.

16. Kim KH, Cho KS, Ham WS, Hong SJ, Han KS. Early application of permanent metallic mesh stent in substitution for temporary polymeric ureteral stent reduces unnecessary ureteral procedures in patients with malignant ureteral obstruction. Urology. 2015; 86:459–464.

17. Chung HH, Kim MD, Won JY, Won JH, Cho SB, Seo TS, et al. Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion. Cardiovasc Intervent Radiol. 2014; 37:463–470.

18. Chow PM, Chiang IN, Chen CY, Huang KH, Hsu JS, Wang SM, et al. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents. PLoS One. 2015; 10:e0135566.

19. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003; 14(9 Pt 2):S199–S202.

20. Denstedt JD, Wollin TA, Reid G. Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation. J Endourol. 1998; 12:493–500.

21. Liatsikos EN, Karnabatidis D, Katsanos K, Kallidonis P, Katsakiori P, Kagadis GC, et al. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment. J Urol. 2009; 182:2613–2617.

22. Barbalias GA, Liatsikos EN, Kalogeropoulou C, Karnabatidis D, Zabakis P, Athanasopoulos A, et al. Externally coated ureteral metallic stents: an unfavorable clinical experience. Eur Urol. 2002; 42:276–280.

23. Kim M, Hong B, Park HK. Long-term outcomes of double-layered polytetrafluoroethylene membrane-covered self-expandable segmental metallic stents (Uventa) in patients with chronic ureteral obstructions: is it really safe? J Endourol. 2016; 30:1339–1346.